News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Epitomics, Inc. Plans Taiwan IPO Later in 2011



8/19/2011 9:22:26 AM

August 18, 2011 -- Epitomics, the San Francisco-area biopharma with two major facilities in China, intends to IPO on the Taiwan Stock Exchange before the end of the year. Epitomics’ business model is based on the company’s proprietary RabMAb® monoclonal antibody technology, which the company says provides better antigen recognition than the more common mouse models. Because the company is still awaiting approval from the Taiwan Stock Exchange for the IPO, the company has not released details of the transaction. More details....

Read at ChinaBio Today


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES